Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Ph...

FDA Recall #D-0389-2024 — Class III — March 4, 2024

Recall #D-0389-2024 Date: March 4, 2024 Classification: Class III Status: Terminated

Product Description

Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-201-20

Reason for Recall

Cross Contamination with Other Products:(mycophenolate mofetil).

Recalling Firm

Novitium Pharma LLC — East Windsor, NJ

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

3,940 1000-count bottles

Distribution

Nationwide in the USA

Code Information

Lot #: M23172A, Exp 01/31/2025

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls